Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

Stock Quote Disclaimer: Copyright © 1998-2002 MarketWatch.com Inc. User agreement applies. Historical and current end-of-day data provided by Interactive Data Corp. Intraday data is at least 20-minutes delayed. All times are EDT. Intraday data provided by S&P Comstock and subject to terms of use.

NYSE | BMY 22.12 | +0.23 | 4:02 PM EDT | 24 Jul 2008

Top Stories

Bristol-Myers Squibb
Continues Strong
Financial Performance
Led by Double-Digit
Global Sales Growth
Press Release (HTML) >>
Press Release (PDF) >>

Latest News
07.24.2008>>Bristol-Myers Squibb Continues Strong Financial Performance Led by Double-Digit Global Sales Growth 07.23.2008>>Bristol-Myers Squibb and AstraZeneca Submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA(TM) (saxagliptin) for the Treatment of Type 2 Diabetes 07.21.2008>>Bristol-Myers Squibb Names Chief Procurement Officer